Skip to main content

Table 1 Baseline demographic, disease and psychological variables

From: Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study

Variable   N (%) M(SD) Observed range
Total N   56   
Demographics     
Female, N (%)   44 (78.6)   
Mean age    53.6 (13.4) 26–83
Ethnicity, N (%) White 35 (64.8)   
  Asian 7 (13.0)   
  Black 11 (20.4)   
  Mixed 1 (1.9)   
  Not reported 2 (3.8)   
Disease characteristics (baseline)    
Mean disease duration (Years)   10.3 (9.2) 0.2–38
Experiencing comorbidity, N (%) 32 (57.1)   
Treatment type, N (%) DMARD 38 (67.9)   
  Biologics 14 (25.0 %)   
  Not reported/other 4 (7.1 %)   
Rheumatoid factor positive N (%) 40 (71.4)   
Median ESR (IQR)    27.0 (12.0–44.0) 2–102
Mean TJC    5.2 (6.1) 0–24
Mean SJC    3.0 (2.9) 0–10
Mean PGA    45.8 (25.0) 1–90
Mean DAS-28    4.5 (2.2) 0.9–14.1
Clinical remission (DAS-28 < 2.6), N (%) 8.0 (14.6)   
Psychological status (baseline)    
Mean depression    7.4 (4.7) 0–20
Mean anxiety    7.7 (5.0) 0–20
Disease characteristics (follow-up)    
ESR, median (IQR)    22.5 (8.0–44.0) 2–114
TJC, M (SD)    4.0 (5.8) 0–28
SJC, M (SD)    3.2 (3.8) 0–16
PGA, M (SD)    44.6 (26.1) 1–100
DAS-28, M (SD)    4.7 (2.8) 0.5–17.1
Clinical remission (DAS-28 < 2.6), N (%) 8.0 (16.0)   
  1. M mean, SD standard deviation, DMARD disease modifying anti-rheumatic drug, NSAID non-steroidal anti-inflammatory drug, ESR erythrocyte sedimentation rate, TJC tender joint count, SJC swollen joint count, PGA patient global assessment, DAS-28 28 joint disease activity scale, HADS-D hospital anxiety and depression scale depression subscale, HADS-A hospital anxiety and depression scale anxiety subscale